Bacteria and Cancer

Herausgegeben:Khan, Abdul Arif

• Gebundenes Buch

Produktbeschreibung

Bacterial infections cause substantial morbidity and mortality in cancer patients. These infections always remained enigmatic due to initial reluctance of cancer researchers in understanding their etiologic potential. Etiological association of bacteria with cancer gained credibility after discovery of carcinogenic potential of Helicobacter pylori. Moreover, other suspected associations including Salmonella typhi and gallbladder cancer, Streptococcus bovis and colon cancer and Chlamydia pneumoniae with ocular adnexal lymphoma etc. are looking for a legitimate appraisal to unravel their etiologic potential without prejudice. In contrary, bacteria also shows protective role for certain types of cancer. Certain agents derived from bacteria are successfully used for the management of cancer. The integrate association of bacteria and cancer association is evident in both positive and negative aspects. The role of bacteria in cancer etiology and treatment has been vigorously studied since last few years. Present book tries to provide current status of research undergoing in above direction, with the glimpses of future possibility for utilizing microbiological knowledge in the management of this deadly killer. This book will interest specialist dealing with cancer associated infectious complications, researchers working in the field of cancer biology, teachers and scientist in the field of microbiology, biotechnology, medicine and oncology. The unique coverage of bacteriology and cancer association in both positive and negative way can usher into to development of novel thrust area for microbiology students and experts.

Produktdetails

• Verlag: Springer / Springer Netherlands
• Artikelnr. des Verlages: 80112844
• 2012
• Seitenzahl: 284
• Erscheinungstermin: 3. Januar 2012
• Englisch
• Abmessung: 241mm x 160mm x 20mm
• Gewicht: 608g
• ISBN-13: 9789400725843
• ISBN-10: 9400725841
• Artikelnr.: 33836607

Inhaltsangabe

Epidemiological indication about bacterial infections associated with cancer.-2. Gastric cancer and Helicobacter pylori.-3. Streptococcus bovis and colorectal cancer.-4 Chlamydial diseases: A crossroad between chronic infection and development of cancer.-5. Salmonella typhi and gall bladder cancer.-6. Ocular adnexal lymphoma of MALT type and its association with Chlamydophila psittaci infection.-7. Possible strategies of bacterial involvement in cancer development.-8. Bacteria as a therapeutic approach in cancer therapy.-9. Targeting cancer with Amino-acid auxotroph Salmonella typhimurium A1-R.- 10 . B acterial asparaginase: A potential therapeutic agent for treatment of acute lymphoblastic leukemia.-11. Can Bacteria evolve anticancer phenotype?-12. Management of bacterial complications in cancer patients. Index.

---

Epidemiological indication about bacterial infections associated with cancer.-2. Gastric cancer and Helicobacter pylori.-3. Streptococcus bovis and colorectal cancer.-4 Chlamydial diseases: A crossroad between chronic infection and development of cancer.-5. Salmonella typhi and gall bladder cancer.-6. Ocular adnexal lymphoma of MALT type and its association with Chlamydophila psittaci infection.-7. Possible strategies of bacterial involvement in cancer development.-8. Bacteria as a therapeutic approach in cancer therapy.-9. Targeting cancer with Amino-acid auxotroph Salmonella typhimurium A1-R.-10. Bacterial asparaginase: A potential therapeutic agent for treatment of acute lymphoblastic leukemia.-11. Can Bacteria evolve anticancer phenotype?-12. Management of bacterial complications in cancer patients. Index.

Rezensionen

From the reviews:

"This is a specialist text ... aimed at those Clinicians involved in treating infectious complications of cancer. It is also relevant to researchers and scientists in the field of microbiology and biotechnology as well as medicine. ... The aim of this book is to provide the current status of ongoing research and attempts to use microbiological knowledge in the management of cancer." (Karin Baria, Oncology News, Vol. 7 (6), January/February, 2013)